Abstract
One of the CDC 2011 1A recommendations for the prevention of Catheter-Related Bloodstream Infections (CRBSIs) is the use of antimicrobial Central Venous Catheters (CVCs). Mostly, CRBSIs are mono-microbial in nature and are well studied; however, poly-microbial infections, which are more difficult to treat, are less understood. Therefore, this study was designed to evaluate the effectiveness of Chlorhexidine-Silver Sulfadiazine (CH-SSD), Minocycline-Rifampin (MR), and Silver-Carbon-Platinum (SCP) treated CVCs in reducing mono- and poly-microbial colonization's under in vitro conditions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
